ALKBH5-mediated CHAC1 depletion promotes malignant progression and decreases cisplatin-induced oxidative stress in gastric cancer
sensacin en la piel: deja una sensacin tonificante y fresca
Multi-omics analysis of diabetic heart disease in the db/db model reveals potential targets for treatment by a longevity-associated gene
The 2023 International Evidence-Based Guideline for PCOS, published before the PMOS name change, stated that anti-obesity medications, including GLP-1 receptor agonists such as liraglutide and semaglutide, could be considered in addition to lifestyle intervention for adults with PCOS and higher weight
Continuous GLP-1RA use for three years was associated with the greatest reduction in MACE risk compared with sulfonylureas, whereas interruptions and discontinuations were associated with a progressive attenuation of this protective effect, with risk estimates in some scenarios approaching those of the comparator group
The potential relationship between GLP-1 receptor agonists and alcohol consumption has emerged from both preclinical research and anecdotal clinical observations
